Bacil Pharma Ltd — Results, 26-05-2025: Result

Bacil Pharma Limited has announced a board meeting and approved the audited financial results for the quarter and year ended March 31, 2025, with an unmodified auditor’s opinion. The company reported a total revenue of Rs. 8.77 lakh for the quarter and Rs. 66.14 lakh for the year, with a net profit of Rs. 1.56 lakh for the quarter and Rs. 40.05 lakh for the year. The balance sheet shows a significant increase in investments and equity, with total assets rising to Rs. 2560.02 lakh from Rs. 132.61 lakh the previous year. Cash and cash equivalents jumped to Rs. 285.73 lakh from Rs. 4.15 lakh, supported by strong cash flows from operations and financing. The auditor noted outstanding loans and advances due to lack of confirmation, indicating some risk around recoverability.